|
Post by dstevenson on Jan 30, 2016 23:51:44 GMT -5
They're having it on feb third cause we're getting $23 for the buy out....
I am half kidding
|
|
|
Post by patten1962 on Jan 31, 2016 0:03:01 GMT -5
They're having it on feb third cause we're getting $23 for the buy out.... I am half kidding God, that would be awesome!
|
|
|
Post by coo2002coo on Jan 31, 2016 0:46:11 GMT -5
Update the progress on Afrezza transition and keep pressuring SNY to expedite the work so that MNKD will be able to regain control and market the drug asap?
|
|
|
Post by mnholdem on Jan 31, 2016 9:38:33 GMT -5
Sanofi is required to provide a transition plan to MannKind. Perhaps at the CC Matt will be able to elaborate on the timeline of how all the marketing materials and development data will be returned to MannKind Corporation. One of the answers I'm most interested in hearing is the earliest date that MannKind can take over negotiating with 3rd Party Payers for coverage of Afrezza at its NEW competitive pricing.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 31, 2016 10:56:54 GMT -5
Sanofi is required to provide a transition plan to MannKind. Perhaps at the CC Matt will be able to elaborate on the timeline of how all the marketing materials and development data will be returned to MannKind Corporation. One of the answers I'm most interested in hearing is the earliest date that MannKind can take over negotiating with 3rd Party Payers for coverage of Afrezza at its NEW competitive pricing. I was hoping that MannKind would be able to reduce the price by the time the clinics start opening, but that is unlikely unfortunately.
|
|
|
Post by jpg on Jan 31, 2016 12:38:16 GMT -5
Hopefully to update the Diabetes Care Centers rollout. The critical issue that gets lost is the cost to MannKind; $0. A group of private investors will be funding the clinics. With hundreds planned during 2017 - 2018, I believe this is the most important issue surrounding Afrezza. Where do you get your info from?
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 31, 2016 12:42:49 GMT -5
Hopefully to update the Diabetes Care Centers rollout. The critical issue that gets lost is the cost to MannKind; $0. A group of private investors will be funding the clinics. With hundreds planned during 2017 - 2018, I believe this is the most important issue surrounding Afrezza. Where do you get your info from? From the JPM conference slide.
|
|
|
Post by peppy on Jan 31, 2016 13:06:58 GMT -5
Hopefully to update the Diabetes Care Centers rollout. The critical issue that gets lost is the cost to MannKind; $0. A group of private investors will be funding the clinics. With hundreds planned during 2017 - 2018, I believe this is the most important issue surrounding Afrezza. Where do you get your info from? Number 1 rule? read the chart. content.screencast.com/users/mpeppy/folders/Jing/media/31464366-085f-4e2d-9cdf-0a0ede3c5100/2016-01-13_1906.png
|
|
|
Post by trondisc on Jan 31, 2016 14:11:38 GMT -5
...forgot to include they will announce more news that they are delaying positive news until end of 2016 or 2017. Cannot believe I've become a bagholder prisoner when all I was trying to accomplish was support a company who can help change modern medicine with their Technosphere devices. Maybe good will triumph over all the evil/hate against this company really making something revolutionary. At this point I've accepted I won't break even at 2.99 and diabetics worldwide have been deprived unfortunately of Afrezza. Guess I'm lame thinking I could believe and make a positive difference.
If I had made a killing on this stock, I had this creative idea to take that profit and offer/solicit one free Afrezza for every certified diabetic user on Twitter as a way of recognizing MannKind's important contribution and commitment to survive in the name of helping others. Damn my philanthropic stock picking intentions.
|
|
|
Post by jpg on Jan 31, 2016 14:38:28 GMT -5
Where do you get your info from? Number 1 rule? read the chart. content.screencast.com/users/mpeppy/folders/Jing/media/31464366-085f-4e2d-9cdf-0a0ede3c5100/2016-01-13_1906.png
Number 2 rule: read the chart meaning well? I read 1 pilot centre in New Jersey for Q1 2016 and then an option for a ramp up.
|
|
|
Post by jpg on Jan 31, 2016 15:22:27 GMT -5
I posted about Ascensia earlier. They reason this is interesting is the location: Parsippany, NJ First diabetes care center to run with Afrezza will open somewhere in New Jersey this quarter. Then it's got to be J and J! www.google.ca/?gws_rd=ssl#q=j+and+j+headquartersor Merck www.google.ca/?gws_rd=ssl#q=merck+headquartersI hear there are other companies in NJ? I could be them. Or not... Laker and co. are just trowing stuff hoping something sticks. We went from one pilot clinic in NJ to 100s across the county and now it seems we even know who is leading all this. This is just pure speculation.
|
|
|
Post by cgiscgis on Jan 31, 2016 15:26:40 GMT -5
Ascensia is owned by Panasonic.
|
|
|
Post by kpm1028 on Jan 31, 2016 18:17:06 GMT -5
With out current cash position I would love to know when we can put that 200 million on the book under the agreement with sanofi we could not show that money on the books but with the agreement over that should make the books look much better.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 31, 2016 18:34:39 GMT -5
For some reason the information regarding the Afrezza clinics gets distorted. The first clinic will open during Q1 in NJ with additional clinics to follow nation wide. These clinics will be independent of MannKind; INVESTOR LEAD.
Hopefully this ends the confusion, but I suspect not.
|
|
|
Post by suebeeee1 on Feb 1, 2016 0:39:22 GMT -5
There are over 100 pharmaceutical biotech companies in nj, there are over 100 endocrinologist and there are 72 acute hospitals. Unless someone actually has a real line into this, I suggest we wait until we have more news. You could take any number of guesses and it would be no more than a shot in the dark. I'll be listening in on the conference call hoping for more info about this.
|
|